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ABSTRACT 
The Thy-1 antigen is a normal c e l l  surface  component of mouse 
f i b r o b l a s t s  , bra in  c e l l s ,  and thymus-derived lymphocytes  ce cells ) , 
This t h e s i s  presents  t h e  r e s u l t s  of genet ic ,  phylogenetic, develop, 
mental, and physiological  s tud ies  of t h i s  antigen and i ts  rat analog, 
8-R . 
The T h y 4  locus ,  which controls  t h e  expression of t h e  Thy-1 
antigen,  was previously shown t o  be located  on Chroaosome 9 of t h e  
mouse. It has been mapped more precise ly  by following i t s  segregation 
r e l a t i v e  t o  t h e  l inked markers Trf and Modml. This group of genes w i l l  
probably be use fu l  i n  fu tu re  genet ic  s tud ies  of t h i s  chromosome, 
Sublines of t h e  inbred AKR mouse s t r a i n  have been typed f o r  a 
v a r i e t y  of genetic markers, Differences were found i n  Thy-1 ant igen,  
cytoplasmic malic enzyme, kidney esterase-3,  p r inc ipa l  ur inary  p ro te in ,  
expression of Murine Leukemia Virus-= antigen and incidence of leu- 
a kemias. Those subl ines  homozygous f o r  Thy-1 appeared t o  show an 
increased s u s c e p t i b i l i t y  t o  spontaneous leukemia as  compared with those 
homo zygous f o r  ~ h ~ - l ~ .  
Thymocytes from r a t s  of 1 3  d i f f e r e n t  inbred and 2 random-bred 
populations were found t o  express an antigen indis t inguishable  from 
Thy-1.1. A t  b i r t h  l i t t l e  o r  none of t h i s  antigen was present  i n  r a t  
bra in .  Soon afterward an approximately logarithmic increase i n  antigen 
expression began. This continued u n t i l  about day 20 when t h e  adu l t  
l e v e l ,  which exceeded t h a t  i n  neonatal bra in  by more than 100-fold, was 
reached, 
Absorption and complement-mediated cy to tox ic i ty  t e s t s  f a i l e d  
t o  de tec t  t h e  Thy-1.1-like antigen (0-R) on r a t  lymph node, spleen,  
o r  bone marrow c e l l s .  Pretreatment of immune rat pe r i tonea l  exudate 
c e l l s  with anti-Thy-l,l  ant ibodies  i n  t h e  presence of cmplement d id  
not abol ish  t h e i r  a b i l i t y  t o  k i l l  tumor c e l l s  i n  v i t r o ,  These r e s u l t s  
-' -
suggest t h a t  t h e  expression of t h e  8-R antigen by r a t  thymus-derived 
lymphocytes not only decreases during maturation, a s  i s  t h e  case i n  
t h e  mouse, but  ceases a l toge the r ,  
b Contrary t o  t h i s  conclusion i s  t h e  f inding t h a t  Thy-1 - 
-
homozygous mice immunized agains t  r a t  per iphera l  lymphocytes made 
antibodies d i rec ted  agains t  Thy-1.1, It the re fo re  appears t h a t  small. 
amounts of t h e  6-R antigen a r e  i n  f a c t  expressed by rat pe r iphera l  
thymus-derived lymphocytes. 
Following s u i t a b l e  absorptions,  a n t i s e r a  prepared i n  r a t s  
agains t  thyxmcytes from n i c e  hcnczygcus f o r  t h e  T @ - + ~  a l l e l e  co?dd 
be rendered s p e c i f i c  f o r  Thy-1.2, Antibodies d i rec ted  agains t  one or  
more o ther  mouse a l loant igens  could a l s o  be detec ted  i n  these  a n t i s e r a ,  
The re la t ionsh ip  of these  r e s u l t s  t o  t h e  current  l i t e r a t u r e  on 
Thy-1 i s  discussed. 
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I. INTRODUCTION 
The introduction of foreign substances into the tissues of an 
animal may have a number of effects, Many such materials can be filT 
tered by the kidneys or removed by phagocytic cells such as those of the 
liver or spleen. In addition to these relatively nonspecific reactions, 
higher animals are also capable of making immune responseswhich are 
specific for foreign molecules to which the animal has been exposed 
previously. The altered state of an anual following such a response 
may be described in terms'of three categories: humoral immunity, eelr 
lular immunity, and tolerance. In the first case, the immune response 
is mediated by antibody molecules, which are soluble glycoproteins 
present in most bodily fluids, Antibodies are capable of specifically 
combining with the foreign substance which gave rise to the immune 
response. The formation of these complexes may cause greatly enhanced 
specific phagocytosis. Also, the attachment of antibodies to the sur- 
faces of foreign cells can result in membrane damage and eventually 
cytolysis. This is accomplished through the interaction of the 
attached antibodies with a series of serum components collectively 
referred to as the complement system (1). 
Cellular immune responses differ from humoral responses in that 
they produce legions of specifically sensitized cells rather than 
soluble antibodies. Physical contact between immune cells and "target" 
cells (for exmple, the cells of an organ transplanted from a geneticc 
ally disparate individual) can bring about the death of the target cells 
as well as the release of a variety of biologically active molecules (2). 
The t h i r d  type of immune response does not produce dem~ns t rab le  
humoral or  c e l l u l a r  immunity, but  r a t h e r  a s t a t e  of s p e c i f i c  non- 
responsiveness t o  f u t u r e  challenges with t h e  same substance, The 
de ta i l ed  re la t ionsh ip  of to lerance  induction t o  humoral and c e l l u l a r  
responses remains r e l a t i v e l y  obscure although a g rea t  dea l  of work has 
been done i n  t h i s  a rea  (3 ) .  
Substances capable of c a l l i n g  f o r t h  an immune response a r e  
re fe r red  t o  as ~mmununo$ens, while those which r e a c t  s p e c i f i c a l l y  with 
t h e  end products of immune responses ( e  ant ibodies  o r  sens i t i zed  
c e l l s )  a r e  c a l l e d  antigens.  In  p rac t i ce ,  t h e  same physical  e n t i t y  can 
of ten  serve as e i t h e r  an imunogen o r  an antigen,  depending upon whether 
it i n t e r a c t s  with t h e  a f f e r e n t  o r  e f fe ren t  a r c  of t h e  immune response. 
The antigens of primary i n t e r e s t  i n  t h e  context of t h i s  r epor t  
a r e  those present  on t h e  surfaces of mammalian c e l l s .  A number of such 
antigen systems have been described, each with i t s  own proper t ies  and 
experimental advantages. One example i s  t h e  Forssman antigen ( b ) ,  
which i s  widely d i s t r i b u t e d  throughout t h e  t i s s u e s  of many species .  
It can be r e a d i l y  assayed by t h e  complement-dependent l y s i s  of sheep 
red  blood c e l l s ,  and has proven t o  be amenable t o  chemical ana lys i s ,  
A s  a r e s u l t ,  t h e  complete chemical s t r u c t u r e  of t h i s  c e l l  surface  corn- 
ponent has been elucidated ( 5 ) .  
In  contras t  with t h e  Forssman system, some antigens a r e  r e s t r i c t e d  
t o  only a s i n g l e  species or  t i s s u e ,  Ekperiments such as  those  of Frye 
and Edidin ( 6 )  have shown t h a t  species-specif ic  antigens can a c t  a s  
use fu l  l a b e l s  f o r  t h e  study of t h e  dynamic p roper t i e s  of c e l l  membranes. 
The discovery of t i ssue-speci f ic  antigens,  f o r  example, t h e  thymic 
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lymphocyte-specific TL ( 7 )  o r  Thy-1 ( 8 )  systems of mice, has f a c i l i -  
t a t e d  t h e  i d e n t i f i c a t i o n ,  l o c a l i z a t i o n ,  and f rac t iona t ion  of c e l l  
populations ( 9 )  and aided i n  t h e  discrimination of  tumor c e l l  types 
(10). Developmental s tud ies  of these  antigens have provided new 
information about t h e  rev i s ions  i n  c e l l  surface  a r c h i t e c t u r e  which 
accompany t h e  process of c e l l u l a r  d i f f e r e n t i a t i o n  (11). 
Cel lu lar  antigens may a l s o  show gene t i ca l ly  control led  v a r i a t i o n  
within a s i n g l e  species ,  Blood group antigens have become use fu l  
genetic markers i n  a number of species ,  including t h e  human (12) .  
The analys is  of blood group antigens has a l s o  contr ibuted t o  knowledge 
i n  t h e  area  of systemic as opposed t o  autonomous gene expression. 
Although most well-defined c e l l u l a r  antigens a r e  t h e  products of t h e  
c e l l s  upon which they r e s i d e ,  o thers  such a s  t h e  J antigen of c a t t l e  
(13) ,  t h e  R antigen of sheep (14  ) , or  t h e  Lewis antigens of t h e  human 
(15) may be passively adsorbed onto otherwise negative c e l l s ,  
I n  addit ion t o  learning about t h e  normal s t r u c t u r e  and function 
of c e l l s  through t h e  study of t h e i r  surface antigens,  it i s  a l s o  pos- 
s i b l e  t o  study certain pathological  s t a t e s  as evidenced by deviat ions 
from t h e  normal p a t t e r n  of antigen expression, The in fec t ion  of c e l l s  
with v i ruses  frequently gives r i s e  t o  d i s t i n c t i v e  surface  antigens 
( 6 , ) .  The emergence of tumor-specific c e l l  surface  antigens (18) 
and t h e  re-expression of f e t a l  antigens (19,20) a r e  frequent concomi- 
t a n t s  of neoplas t ic  transformation (21), I n  many cases t h e  ant igenic  
s p e c i f i c i t y  of these  tumor antigens reveals  whether a  given neoplasm 
w a s  induced by v i r a l  o r  chemical agents (18). 
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By now it should be apparent that the antigenic composition of 
a mmalian cellrs plasma membrane contains a great deal of information 
regarding the organism from which it came. The model system which I 
have studied is the Thy-1 or theta antigen of mice and rats, Several 
kinds of information revealed by analyses of Thy-1 expression in various 
cell populations will be considered in the following pages, 
The genetic determination of Thy-1 antigenicity in mice, which 
is treated primarily in chapter 2, forms an underlying basis for the 
remainder ofthe work. In chapter 3 the use of T h y 4  as a genetic 
marker is further illustrated and the issue of its possible association 
with leukemogenesis is raised. The various genetic, anatomical, dev- 
elopmental, and phylogenetic factors affecting Thy-1 expression are 
discussed in chapter 4. Finally, it is shown in chapter 5 that anti- 
bodies specific for Thyrl and at least one other genetically controlled 
mouse cell surface antigen can be produced in rats. This finding is 
in accordance with expectations based upon the antigenic relationship 
between the two species outlined in chapter 4. 
11. LOCATION OF THE GENE FOR THETA ANTIGEN IN THE MOUSE 
p'litiicatl~jri contained i n  this chapter is fro3 the  
Journal - of Heredity, It is reproduced here with the permission 
of the American Genetic Association. 
Reprinted from the Journal of Heredity, Vol. 63,  No. 5, September-October, 1972 
Copyright 1972 by the American Genetic Association. 
Location of the Gene for Theta Antigen 
in the Mouse 
T HETA (determined by the Thy-1 locus2" is a cell-surface antigen found on mouse thy- mus-derived lymphocytes and in the brain17. 
Because it is expressed in increasing amounts in 
developing prenatal thymus and early postnatal 
brainxLx8, it is a convenient marker for the differen- 
tiation state of cells in both tissues. The expression 
of theta is controlled by an autosomal gene with 
two known codominant alleles : Thy-la and Thy-l b. 
The mouse strains AKR/J and C3HeB/Fe were 
used in the reciprocal thymus cell immunizations 
that produced the original cytotoxic antibody re- 
agents for this antigenx7. 
Itakura et aL9 demonstrated Iinkage between the 
markers dilute (d )  and Thy-1, placing Thy-1 in link- 
age group 11. The distance between these two mark- 
ers was shown to be 16.8 r 3.8 map units. How- 
ever, it was not determined on whichLside of d the 
Thy-1 gene resided. The purpose of the present study 
was to define the position of Thy-1 in linkage group 
11, which has now been identified as chromosome 93. 
Our experimental design was to measure the re- 
combination between Thy-1 and Trf, the gene con- 
trolling an iron-binding serum protein, transferrin. 
Previously, Trf had been placed distal to d with 
respect to the centromere in linkage group 11'" By 
observing the frequency of recombination between 
Thy-1 and Trf, we expected to locate Thy-1 more 
precisely. In addition, we followed the segregation at 
the H-14 locus, which has not previously been as- 
signed to any linkage g r ~ u p l " ~ ~ .  This locus, also 
known as Ea-2,  determines a red-blood cell antigen. 
During the course of our experiment, Itakura 
et al.'" reported the linkage of the cytoplasmic malic 
enzyme locus, Mod-], to Thy-1 and d. We also re- 
port data regarding the Iinkage of this marker, which 
was segregating in our cross. 
Materials and Methods 
The FI and backcross generations were bred from 
CBA/J and RF/J mice obtained from The Jackson 
Elizabeth Blankenhorn is a research assistant and Tommy 
Douglas is a graduate student in the Division of Biology, 
California Institute of Technology, Pasadena, California 
91 109. This research was supported by Atomic Energy 
Commission contract A T  (04-3)-767 and a National 
Defense Education Act fellowship. The authors wish to 
express their appreciation to Professor Ray D. Owen for 
his advice and encouragement during the course of this 
Laboratory, Bar Harbor, Maine. Samples of blood 
from the tails of individually numbered mice were 
typed for both H-14 and transferrin. Red blood cells 
collected into Gibson's CPD anticoagulant were 
washed three times in ice-cold saline and tested for 
H- 14 by the PVP hemagglutination methodz6. Serum 
recovered from depression plates was separated by 
starch gel electrophoresis and stained with 0.25 per- 
cent Coomassie Blue to identify transferrin pheno- 
type~~~~"Figure  l ) . Mice were thymectomized 
under anesthesiaQnd the thymus cells typed for 
FIGURE 1-Patterns obtained by starch gel electro- 
phoresis of sera from mice of transferrin types b / b  
(left), a / b  (middle), and a /a  (right). Anode at top 
of picture. 
study. 
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theta by direct cytotoxicity using a modification of phenotypes of the backcross progeny were consistent 
the method of Amos et al.'. In later studies, mice with the codominant expression of these markers. 
were sacrificed and the kidneys and thymus were 
removed. Kidneys were typed for malic enzyme using 
the method of Shows and RuddleZo with the following 
modifications: A 12 percent Connaught starch gel 
was made in 0.008 M Tris 0.003 M citrate, pH 6.1, 
and poured into a horizontal Plexiglass template con- 
taining 12 upright teeth, which provided sample 
wells. Kidney preparations were mixed with equal 
volumes of 2 percent Seaplaque agarose (Marine 
Colloids, Inc., Rockland, Maine) at 37°C. Samples 
were added when the gel was cool and run hori- 
zontally at 4°C with 0.223 M Tris 0.086 M citrate 
(pH 5.6)  tank buffer for 5-6 hours at 300 volts 
(Figure 2 ) .  
Results 
Reciprocal crosses were made between mice of 
strains CBA/J and RF/J. The F, progeny were then 
backcrossed to mice of the parental strains. Back- 
cross progeny were typed for theta, transferrin, malic 
enzyme, and H-14. Mice of strain CBA/J have the 
genotype Thy-I", Trp ,  Mod-I", and H-I#", while 
RF/J animals are Thy-l( ' ,  Trfb, Mod-1 ( I ,  and H-  14". 
Because all four of the markers examined in this 
cross are expressed in a codominant fashion, the 
genotype of -the gamete received from the hybrid FIGURE 2-Patterns obtained by starch gel electro- parent can be inferred directly. Therefore, in Tables phoresis of kidney from mice of Mod-I types I through 111, only those alleles inherited from the a/, (left), a / b  (middle), and b / b  (right). Cathode at 
hybrid parent are listed. In all cases, the observed top of picture. 
Table I. Recombination data for Trf, Mod-I, and Thy-1 
Hybrid gamete CR x C* C X CR CR X R R X CR 
Parental 
T r y  Mod-I Thy-1 
~ r f ~  Mod-la Thy-la 
Recombinant, Trf - Mod-1 
Recombinant, Mod-1 - Thy-I 
Trfa Mod-1 Thy-la 
~ r f ~  Mod-I a Thy-1 
Double recombinant 
Total 
Recombination percentages 
Trf - Mod-] 
Mod-I - Thy-1 
Trf - Thy- I 
* Strain CBA/J is abbreviated as C, strain RFlJ as R, and F ,  hybrids are designated CR 
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Three-point recombination values for the segrega- 
tion of Thy-I, Mod-1, and Trf are given in Table I. 
The lack of recombinants of the reciprocal types 
Trf"-Mod-la-Thy-1 and TrfLMod-1"-Thy-1 a indi- 
cates that the gene order is Trf-Mod-1-Thy-I. 
Additional animals were typed for Trf and Thy-2 
only. The results are given in Table 11, which in- 
cludes the data from Table I. The pooled estimate 
of the recombination frequency for crosses in which 
the hybrid parent was female, with each estimate 
weighted by the reciprocal of its variance, is 39.6 4 
3.9 percent. The estimate for recombination in the 
male, calculated in the same way, is 36.3 t 5.0 
percent. The estimates for the two sexes were tested 
for homogeneity and pooled in the manner described. 
The overall recombination frequency between Trj 
and Thy-I is 38.3 t 3.1 percent. 
Recombination data from progeny typed only 
for Trf and, Mod-1 are shown in Table 111, which also 
includes the data from Table I. Using the same meth- 
ods as described for the Trf-Thy-1 data, estimates 
of 21.1 3.9 percent and 7.7 t 2.4 percent were 
obtained for recombination frequencies between Trf 
and Mod-1 in the female and male, respectively. 
When tested for homogeneity, these estimates were 
significantly different (P < .01). The arithmetic 
average of these percentages is 14.4 percent. No sig- 
nificant difference was found, however, between the 
female and male recombination frequencies for Mod-I 
and Thy-I. The pooled estimate for females is 
21.0 t 4.1 percent, and that for males is 25.4 -e 
4.6 percent. The overaII estimate of the distance be- 
tween Mod-I and Thy-1 is 22.9 , 3.1 percent. 
Results from 102 backcross animals failed to in- 
dicate linkage between H-14 and either Trf or Thy-1. 
The observed recombination frequencies were: Trf-L 
H-14, 46.6 _+ 4.9 percent; and Thy-I-H-14, 
51.0 t 5.0 percent. This finding is in accord with 
that of Itakura et al.Io. 
The gene for albinism (c,  chromosome 7) and 
the gene for nonagouti (a, chromosome 2)  could 
be followed in our cross. Both H-14 and the markers 
of the three-point tests on chromosome 9 assorted 
independently of both coat-color markers. 
Table 11. Two-point recombination data for Trf and Thy-1 
Hybrid gamete CR X C* CX CR CRX R R X CR 
Parental 
Recombinant 
~ r f  Thy-1 
Trfa Thy - la  
Total 59 
Recombination percentage 42.4 + 6.4 
* Abbreviations same as those used in Table I 
Table 111. Two-point recombination data for Trf and Mod-I 
-- - - -- - 
Hybrid gamete CR x C* C X CR CR x R R x CR 
Parental 
Trf Mod-1 a 
Trfn Mod- 1 
Recombinant 
Total 3 9 
Recombination percentage 17.9 + 6.1 
* Abbreviations same as those used in Table I 
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Discussion 
Chromosome 9 of the mouse was reviewed sev- 
eral years ago by Green and Lane7. In addition to 
the standard published linkage mapG, an updated ver- 
sion has been compiled by M. C. Green (personal 
communication). Several markers have been added 
to this linkage group since 1967, including Fv-2'" 
(which influences the response to Friend leukemia 
virus), Mod-1, Thy-1, and a new hair deficiency 
(M. C. Green, personal communication). The 14 
identified loci in this linkage group code for iso- 
enzymes, surface antigens, morphological and be- 
havioral effects, a serum protein, and a coat color 
dilution. Translocations have been useful in deter- 
mining gene order and centromere position for the 
chromosome. Kleinn has reported the location of 
the breakpoint of one translocation [T(9;17) 138 
Ca]* to be between curly whiskers (cw) and short- 
ear (se). Using another translocation, T(9;19) 
163H, Lyon et al." showed that the centromere is 
located at the end of the linkage group beyond cw. 
Itakura et al. were able to assign Thy-I to linkage 
group I1 by virtue of its linkage to dilute (d)". 
In a more recent report by these authors, the gene 
order Mod-1-d-Thy-1 was established by a three- 
point crosslo. The tentative order Thy-1-d-Mod-1 
-1u was suggested on the basis of earlier two-point 
recombination data for d-Mod-I, and Mod-1-lu8, 
which had indicated that the Mod-I locus resided 
between the other two markers. Shreffler2', making 
use of recombination data for Trf-d (12.7 percent) 
and Trf-lu (22.2 percent), located Trf distal to d 
with respect to the centromere. If Thy-1 were also 
distal to d, it would necessarily lie close to Trf. 
Such placement of Thy-1 was also suggested by the 
data of Lilly who ordered the loci with respect to 
Fv-213. The order Fv-2-d-Thy-I with Fv-2 proxi- 
mal to d, was based on recombination results from 
two experiments, one using Fv-2 and tk ,  and the 
other Fv-2, d, and Thy-I. 
Our study demonstrates that Trf and Thy-1 are 
not closely linked, as would be predicted from the 
previous studies and the current map. The observed 
recombination frequency for Trf and Thy-I is 36- 
40 percent. Furthermore, our gene order, Trf-Mod- 
I-Thy-1, may be combined with the order Mod-l- 
d-Thy-1, established by Itakura et al., to provide 
the unambiguous sequence Trf-Mod-I-d-Thy-I. 
The tentative placement of Trf and Thy-1 on the 
same side of d is therefore unacceptable. It remains 
uncertain, however, what the orientation of this se- 
quence is with respect to the outside markers ducky 
( du )  and luxoid (lu). 
To resolve this issue with a three-point cross, the 
outside marker must be chosen carefully, because 
much of the uncertainty regarding chromosome 9 
is due to the nature of the markers themselves. For 
* Chromosome numbers, rather than linkage groups, are 
used in the symbols for translocations in accordance with 
the recommendation of the Cfmmittee On Standardized 
Genetic Nomenclature For Mice . 
example, tk, du, lu, and se have all been reported 
to depress viability greatly in the homozygous state. 
Mice homozygous for staggerer (sg),  lu, and du 
are partially or totally sterile, while low penetrance 
and poor expressivity present additional problems 
with [ U ~ ~ , 2 t  . The orientation of the Trf-Mod-1- 
d-Thy-1 sequence might be resolved by a three- 
point cross with curly whiskers (cw) or another out- 
side marker not affected by the problems mentioned 
above. 
The influence of sex on observed recombination 
frequency in the region between d and Trf, exem- 
plified in this report as well as in that of Shreffler22, 
should be noted. Significantly higher recombination 
in females has not been reported in the region proxi- 
mal to d; it is likewise not found in our animals 
between Mod-1 and Thy-1. The distortion of re- 
combination frequencies by sex differences is found 
often in mice, but the process by which it occurs is 
not understood'. The chromosomal regions where 
higher female crossing over is observed fit into no 
obvious pattern, and even two studies of the same 
region may not agree on the presence of sex distor- 
tion of the recombination fraction. The possibility 
of such recombination differences, especially where 
loci are being ordered by two-point crosses, may tend 
to obscure the true sequence of markers in chromo- 
some 9. The linkage map of this chromosome should 
be used with some caution until the proper sequence 
of existing markers is elucidated. 
Summary 
Reciprocal crosses were made between mice of strains 
CBA/J and RF/J. Segregation of the chromosome 9 
markers Thy-I, Mod-I, and Trf was followed by means 
of backcrosses to the parental strains. These three-point 
data, combined with two-point data for Trf-Mod-I and 
Trf-Thy-I, are consistent with the following map: 
Trf-14- Mod-I-23----Thy-I. Al- 
though the order Trf-Mod-l-d-Thy-l is adequately 
established, the orientation of this sequence with respect 
to the centromere remains in doubt. 
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111. VARIATIONS AMONG SUBLINES OF INBRED AKA MICE 
The publ ica t ion contained i n  this chapter is from Nature New 
Biology. It is  reproduced here with the  permission of MacMillan 
Journals  Ltd. 
(Reprinted from Nature New Biology, Vol. 245, No. 140, 
pp. 8-10, September 5 ,  1973) 
Variations among Sublines of Inbred 
AKR Mice 
THE AKR inbred line of mice, developed as a strain with a high 
incidence of leukaemia, has found wide use in the fields of 
genetics, immunology, virology, and cancer research. While a 
certain degree of variability is expected among sublines derived 
from any inbred strain, rather striking differences have been 
observed among AKR sublines. Because such differences can 
be crucial to the usefulness of AKR mice for biomedical 
research, observations regarding some of these AKR sublines 
have been collected from several laboratories. 
Figure 1 shows a partial history of some of the AKR sub- 
lines examined here. The AKR strain was originally developed 
as "Ak" by Jacob Furth between 1928 and 1936l. Eventually, 
descendants of this stock were sent to Oak Ridge National 
Laboratories by Dr Lynch, where they were maintained by 
random breeding and brother x sister matings. Furth, inciden- 
tally, may have brought some. of his own Ak stock from Dallas 
to Oak Ridge in 1949. This would place the original separation 
of the AKR/J stock from the Oak Ridge pool of AKR mice at 
either 1936 or 1948. 
Serological test results for mice of the AKR sublines J and 
Cum are summarized in Table 12-6. Of particular note is the 
observation that sublines AKR/J and AKR/FuRdA express 
the Thy-1.1 thymus antigen (formerly called 8-AKR)' while 
AKR/FuA and AKR/Cum (ref. 8) express Thy-1.2 (8-C3H). 
All the AKR sublines bearing the Thy-1.2 antigen, including 
AKR/Ka, were probably obtained from the Oak Ridge col- 
lection of AKR mice. 
Data for several biochemical markers are given in Table 2. 
A critical observation is that the sublines differ at Mod-I. This 
gene, which governs the expression of malic enzyme, is located 
on chromosome 9 (LG 11) approximately twenty map units 
from Thy-1 s*lO. Data on the expression of MuLV-gs antigen by 
several of the AKR substrains are presented in Table 3. The 
AKR/FuA subline, which has a relatively low incidence of 
spontaneous leukaemia, also shows decreased expression of the 
MuLV-gs antigen, In contrast, mice of the high-leukaemic 
AKRlFuRdA substrain were invariably MuLV-gs + as judged 
by irnmunofluore~cence~~ and in vivo absorption testslBJ8, even 
when foster nursed to MuLV-gs- mothers of strains C3Hf or 
GR. 
Although the AKR line was originally developed as a high- 
leukaemic line, the available sublines vary considerably in this 
respect. For example, the average incidence of leukaemia in 
mice of subline AKRJFuRdA (generations 5-18) was 92% 
t 
Rhoades (1936. BXS : 1939-1940) 
I 
8ak Ridte (1949) Jackson Laboratories (1948) (Fur th) (AKR/J) 
i I -CIBA, Switzerland-t(l953) AKR/FuA (Amsterdam) 
- ?+Rudali, Paris-(1958) AKRIFuRdA (Amsterdam) 1 
Fig. 1 Lineage of AKR mice. 
(273/297) at age 9 months. Since the period 1959-1963, when 
these data on subline AKRlFuRdA were collected, this subline 
has continued to show a high incidence of spontaneous leukae- 
mia. On the other hand, mice of subline AKR/FuA, during 
generations 16-36, showed a leukaemia incidence of only 36 % 
(1091303) at age 11 months. A sister subline, Fm, developed 
leiikaeinia at a rate s f  20 0/, (451227) at I2 mosths fcr g:rrer:ratiens 
21-35. Preliminary data suggest that the AKR/Cum subline 
may show a lower spontaneous leukaemia incidence than 
AKRIJ, but larger numbers of mice must be studied over a 
longer period before this question can be resolved. When com- 
bined with the genetic data from Tables 1 and 2, these findings 
suggest an association between leukaemogenesis and chromo- 
some 9. Such an association has been reported before in the case 
of Friend virus-induced leukaemias. Fv-2, a gene determining 
susceptibility to this virus, is located on this chromosome14. 
In addition to their variability with respect to spontaneous 
leukaemias, sublines of AKR also differ in their susceptibility 
to transplanted leukaemias. Depending on the primary tumour 
used, resistance to its transplantation may be partial or com- 
plete. In an initial experiment, inocula of AKR/J primary 
leukaemia cells, which were lethal upon transplantation into 
other AKR/J mice, were successfully rejected by AKR/Cum 
mice. The only antigen for which the two sublines are known 
to differ is Thy-1, which may be serving as a histocompatibility 
antigen. It has been reported that A/Thy-1.1 mice (previously 
Table 1 Cell Surface Antigens 
- -- - -- -- --. -- - - - - 
Antigen (LG)* AKR/J AKR/Cum 
Thy-1.1 (11) + - 
Thy-1.2 - 
- 
+ 
Ly-1.1 (XII) - 
Ly-1.2 + + 
Ly-2.1 (XI) f 
- 
+ 
Ly-2.2 - 
Ly-3.1 (XI) + 
- 
+ 
Ly-3.2 - 
TL.1 2 3 (IX) - - 
H-2k' ' ' (IX) + + 
G1x2 + + 
GCSA + + 
* LG indicates linkage group. 
Table 2 Biochemical Genetic Markers 
Marker 
Hbb 
Gpi-I 
Mod- I 
Trf 
Es-3 
Mup-1 
Gpd-1 
Dip-1 
Id-1 
Pgm-1 
Es-1 
AKR/ AKR/ 
om J FuRdA 
(1) d d Q) a a 
0 b b (11) b -* 
@) c a c a
b b 
b b 
W I )  b b 
W I )  a a (XVIII) b b 
AKR/ 
Cum 
AKR/ 
FuA 
* Strain not tested. 
A/BAKR) reject leukaemias from the congenic strain, A/J, 
which expresses the Thy-1.2 antigen16. 
Preliminary genetic studies using the progeny of (AKRICum 
x AKR/J) F l  mice backcrossed to either AKR parent indicate 
that a relative resistance to another primary transplanted 
AKR/J thymoma segregates with the Thy-lb genotype. F1 and 
Thy-la homozygous mice die of the tumour in 17.16 3~0.52 and 
17.42 f 0.60 d, respectively, whereas Thy-1 .l negative mice 
(Thy-lb homozygotes) die of the leukaernia in 23.75 f 0.97 d 
(mean 5s.e.). No association was found between resistance 
and the Mod-1 locus product in the several animals also tested 
for malic enzyme type. In a control experiment, small numbers 
of AKR/Cum mice were preimmunized with either four in- 
jections (intraperitoneal) of lo7 AKR/J liver cells or four in- 
jections of lo7 AKR/J normal thymus cells. Both groups were 
Table 3 Quantitative Immunofluorescenccs Tests for MuLV-gs Antigen in Spleens of Adult Mice of Various AKR Sublines 
Subline 
AKR/J 
AKR/J 
AKR/Ka 
AKR/FuRdA 
AKR/FuRdAfC3Hf$ 
AKR/FuRdAfGR$ 
AKR/FuA 
AKR/FuA 
Laboratory 
Sloan-Kettering Institute 
Department of Radiobiology, Stanford 
Department of Radiobioloipy, Stanford 
Netherlands Cancer Institute 
Netherlands Cancer Institute 
Netherlands Cancer Institute 
Netherlands Cancer Institute 
Netherlands Cancer Institu.te 
Age in 
months 
No. positivelNo. tested 
IFA* DRt 
22/22 313 
212 
12/12 
32/32 919 
111 
313 . 
018 3/10 
216 314 
Titre ABU d-lt 
IFA DR 
1 /41  /1 6 11->15 
118 
114-1/16 
114-1/16 10->15 
15 
114-118 
10, 13, 15 
1/1-1/4 8, 10, >15 
* IFA, Imrnunofluorescence absorption. The antigen titre refers to one volume of a 17 % wet weight extract in 0.85 % saline, which absorbs 
out the immunofluorescence of an equal volume of antiserum, diluted to three double dilutions below the endpoint of the fluorescence (for 
example, 1/64 if the endpoint of fluorescence is 1/512)1. 
t DR, Disappearance rate. ABU d-l refers to the disappearance rate per day of intraperitoneally injected rat anti-MuLV-gs antibodies 
from the serum of adult mice as measured by immunofluorescence. A disappearance rate of less that 2 ABU d'l is considered negative. 
$ Foster nursed to MuLV-gs mothers of strain C3Hf or GR, as indicated. 
able to reject completely a challenge inoculation of 5 x 108 Thy- 
1.1 positive AKR/J spontaneous thymoma cells, whereas the 
unimrnunized AKR/Cum mice died of leukaemia within 23 d. 
Because liver preparations are generally considered Thy-1 
negativea, and because no cytotokic anti-Thy-l . 1 antibodies 
were found in the sera of animals preimmunized only with liver 
cells, further work is in progress to determine the effect(s) of 
factors other than Thy-1 antigenicity in this immune rejection 
phenomenon. 
In summary, sublines of the inbred AKR mouse strain have 
been found to differ with respect to several traits, including the 
Thy-1 antigen, malic enzyme, esterase-3, principal urinary pro- 
tein, expression of MuLV-gs antigen, and incidence of leu- 
kaernias. Within the context of these AKR sublines, the data 
suggest an association between chromosome 9 and leukaemo- 
genesis. Further research in several fields will be required to 
test this hypothesis. For the present, researchers using AKR 
mice should be alerted to the subline variations reported. 
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OCJCURRENCE OF A THETA-LIKE ANTIGEN I N  RATS* 
BY TOMMY C. DOUGLAS 
(From the Division of Biology, Calqorn ia Institute of Technology , 
Pasade %a, California 91 109) 
(Received for publication 26 May 1972) 
The theta antigen, described by Reif and Allen (I), provides a marker for 
thymus-derived lymphocytes in the mouse. The uses of this antigen system 
for studies in numerous fields, including immune system development, cellular 
cooperation, and the distribution of lymphocyte subpopulations, have recently 
been reviewed (2). Expression of the theta antigen is governed by a single 
autosomal locus having two alleles, B A K R  and 8 C 3 H  (3) .  
After immunization with 8-AKR antigen-bearing cells, spleen cells harvested 
from mice homozygous for BC3H have been shown to form plaques against thy- 
mus cells from several inbred rat strains as well as against those of mice carry- 
ing the BAKR allele (4). The present study was undertaken in order to clarify 
the relationship between this rat antigen system and the 8-system of mice. 
Materials and Methods 
Animals.-All inbred rat strains used in this study were obtained from Microbiological 
Associates, Inc., Bethesda, Md., with the exception of strain DA which was kindly provided 
by Dr. Joy Palm, The Wistar Institute, Philadelphia, Pa., and strain D which was originated 
in this laboratory by Dr. Ray D. Owen. AKR/J and C3H/HeJ mice were bought from the 
Jackson Laboratory, Bar Harbor, Maine, and AKK/Cum mice came from Cumberiand View 
Farms, Clinton, Tenn. 
Anti-6 Sera.-Antisera were produced according to the optimal schedule described by 
Reif and Allen (3). Blood was collected from the tail into heparinized tubes, and the plasma 
stored at -20°C until used. 
Cytotoxicity Assay.-The cytotoxic test employed was similar to the one-step microcyto- 
toxicity assay described by Amos (5), except for the substitution of Hanks' balanced salt 
solution (HBSS) for barbital buffer in the thymocyte (TC) suspension, and of 0.3% trypan 
blue in HBSS for 0.25y0 trypan blue in saline. Test cells were preincubated with antiserum for 
15 min a t  room temperature before complement addition. Test plates (No. 3034; Falcon 
Plastics, Div. B-D Laboratories, Inc., Los Angeles, Calif.) were then further incubated for 
20 min at 37OC in a 6.3% COz atmosphere. Exclusion of trypan blue dye was then used as the 
measure of test cell viability. 
Complement.-Rabbit serum diluted 1/3 in HBSS (from which Ca++ and M ~ + +  had been 
omitted) was absorbed with purified agarose (Bio-Rad Laboratories, Richmond, Calif.) at 
0°C for 30 min in the presence of 0.01 M ethylenediaminetetraacetic acid (EDTA) disodium 
* Supported by Atomic Energy Commission contract AT(04-3)-767 and a National De- 
fense Education Act fellowship. 
Abbreviatiolzs used ilz this paper: HBSS, Hanks' balanced salt solution; TC, thymocyte. 
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salt (6, 7). After filtration to remove the agarose beads, divalent cations were restored by the 
addition of CaClz in an amount equimolar to the previously added EDTA. The pH of the 
absorbed serum was brought to approximately 7.4 with 0.1 M NaOH. 0.5-ml aliquots of ab- 
sorbed sera were stored a t  -80°C until shortly before use. 
Sera from rats of strains WF or F344 were used unabsorbed and were diluted 1/4 in HBSS 
before storage at  --80°C. 
Antiserum Dilut ion 
FIG. 1. Killing of AKR/J TC by C3H/HeJ anti-AKR/ J serum. 100-p1 aliquots of serum 
diluted to 1/32 in HBSS were absorbed with the following numbers of th~mocytes: none (aC*), 1 X 10' DA rat TC (0-O), 1 X lo7 AKR/ J TC (A-A). Complement source: 
1/12 agarose-absorbed rabbit serum. 
1 
0 1 I I I I I I 
1/32 1/64 1/128 1/256 1/512 //I024 
Antiserum Dilution 
FIG. 2. Killing of C3H/HeJ TC by AKR/J anti-C3H/HeJ serum. Symbols and pro- 
cedure same as in Fig. 1. Absorption with 1 X lo7 C3H/He J TC (0-0). 
RESULTS 
Using AKR/ J test cells and C3H/He J anti-AKR/ J TC sera, rat thymocytes 
showed an intermediate absorptive capacity, relative to AKR/ J TC (Fig. 1). 
However, using AKR/J anti-C3H/HeJ sera, negligible amounts of activity 
against C3H/He J cells were removed by rat thymocytes while C3H/HeJ TC 
showed strong absorption (Fig. 2). Control absorptions with TC of the serum 
donor's strain were also negative. Qtotosic autoantibodies (8) were not ob- 
served in this system. 
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These absorption results were confirmed by the observation of direct killing 
of rat TC by mouse anti-6 serum in the presence of rat complement (Fig. 3). 
C3H/HeJ anti-AKR/J and AKR/Cum anti-AKR/J TC sera were both 
strongly cytotoxic for rat TC while C3H/HeJ and AKR/Cum normal sera 
were not. Also negative against rat TC were AKR/ J anti-C3H/HeJ TC and 
AKR/ J anti-AKR/Cum TC sera. 
The complement source used to demonstrate the presence of 6-like antigen 
on rat thymocytes was of critical importance, as may be seen from Figs. 4 and 
5. With rabbit complement, C3H/HeJ anti-AKR/J TC serum showed only a 
small differential killing effect. Using rat complement, however, this difference 
was striking. 
Ant iserum Di lut ion 
FIG. 3. Complement-mediated cytotoxicity of WF rat TC by anti-8 serum. Sera: C3H/HeJ 
anti-AKR/ J TC (0-a),  AKR/ J anti-C3H/He J TC (A-A), C3H/He J normal serum 
(0-0). Complement source : 1/4 WF rat serum. 
Preliminary tissue distribution experiments indicated that rat thymus and 
brain had the highest absorptive capacities for C3H/He J anti-AKR/ J TC  
serum while rat liver, heart, testis, lung, skeletal muscle, erythrocytes, Peyer's 
patches, spleen, and peripheral white cells showed substantially less absorp- 
tion. Based upon this observation, a developmental study of @-like antigen in 
the rat nervous system was undertaken. 
Rats were killed with chloroform and perfused with 0.85% NaC1. The 
brains were dissected out, weighed, and homogenized in saline so as to make 
suspensions containing 100 mg of tissue wet weight/ml of homogenate. All 
homogenates were made using Potter-Elvehjem type tissue grinders. Brain 
suspensions were stored at -20°C until used, at which time they were thawed 
and rehomogenized. Measured aliquots of homogenate were centrifuged at 
approximately 2150 g for 5 min and the supernatants discarded. 0.05-ml ali- 
quots of AKR/Cum anti-AKR/J TC serum diluted 4.iss in HBSS were then 
added. Absorptions were carried out for 30 min at room temperature with fre- 
quent stirring. The absorbed sera were centrifuged at 2150 g for 5 min, and 
TOMMY C .  DOUGLAS 
the supernatants tested for residual cytotoxic activity against AKR/J TC. 
Absorptive capacities were determined from von Krogh plots (Fig. 6 19, 101). 
Fig. 7 shows that an approximately logarithmic increase in the rat brain's 
theta-absorptive capacity occurs between birth and approximately day 20, at 
Complement Dilution 
FIG. 4. Cytolysis of WF rat thymocytes by anti-6' serum and agarose-absorbed rabbit 
complement. Cells were incubated with or without anti-6 serum diluted 1/32 in HBSS. C3H/ 
He J anti-AKR/ J serum (8-0) , AKR/ J anti-C3H/He J serum (0-0) , no serum (0- 0) 
Complement Dilution 
FIG. 5. Cytolysis of WF rat thymocytes by anti-6 serum and unabsorbed rat complement. 
Symbols same as for Fig. 4. 
which point the slope of the curve rapidly declines. No significant difference 
in 0-absorptive capacity was observed between male and female rats. 
To date, eight inbred rat strains have been tested for the presence of theta- 
like antigen. By both absorption and direct cytotoxic tests, thymocytes from 
rats of the ACI, BN, BUF, D, DA, F344, LEW, and WF strains all expressed 
antigenic determinants cross-reactive with the 8-AKR mouse antigen (Table 
I). No significant cross-reactivity with the 0-C3H antigen was observed. Wistar 
and Holtzman random-bred rats also gave similar results. 
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DISCUSSION 
Quantitative absorption tests using mouse anti-8 sera and mouse thymocytes 
as target cells showed that rats of the inbred strains tested all expressed an 
antigen which was strongly cross-reactive with the 8-AKR, but not the 8-C3H, 
specificity of mice. The same pattern of cross-reactivity was seen when direct 
FIG. 6. Determination of the theta-absorptive capacities of WF rat brain homogenates 
Postnatal age: 8 days (A-A), 18 days (A-A), 33 days (@--a), 271 days (0-0). 
Serum: AKR/Cum anti-AKR/J TC diluted 1/256 in HBSS. Complement source: 1/18 agar- 
ose-absorbed rabbit serum. 
cytotoxic tests were performed using mouse anti8 sera with rat thymocyte 
target cells. 
The AKR/Cum mouse subline has been shown to be similar to the AKR/J 
subline with reference to several alloantigenic markers (Dr. E. A. Boyse, per- 
sonal communication) while differing at the 8-locus (11). The cross-reactivity 
of AKR/Cum anti-AKR/J sera with rat antigens thus argues strongly that 
the specificity detected is indeed 6 and not some other antigen. 
As has been observed with rat lymphocytes (12) as well as with those of 
other species (13), the complement source used in cytolytic assays can be of 
critical importance. Although rat strains WF and F344 differ at three of the 
24 
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AGE, days 
FIG. 7. Developmental appearance of 8-like specificity in WF rat brain. Absorptive ca- 
pacities are expressed as 8-absorptive units = reciprocal of the number of milligrams of brain 
homogenate required to produce 50% inhibition of cytotoxicity. Serum: same as for Fig. 6. 
At 1 day, theta-absorptive capacity <0.04. 
TABLE I 
Per Cent Rat T C  Killed by Mouse Anti8 Sera 
Serum 
Rat strain AKR/ C3H/ AKR/ AKR/ 
None* Cum anti- 2;Hs HcJ anti- J anti- J anti- 
AKR/J AKR/J C3H/HeJ AKR/Cum 
ACI 18 12 58 11 77 17 19 15 
BN 20 8 60 7 78 22 2 7 19 
BUF 24 6 41 7 81 18 24 17 
F344 11 6 63 5 86 11 7 11 
LEW 13 9 64 3 90 11 9 12 
WF 14 10 77 10 81 16 16 14 
All sera used a t  1/32 dilution in HBSS. Note that this serum concentration does not neces- 
sarily represent a "cytotoxic plateau" for the respective sera, but merely gives a qualitative 
index of cytotoxic activity. Complement source: WF serum diluted 1/4 in HBSS. 
* Preincubated with H I3SS alone. 
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well-defined genetic loci for rat cellular antigens (14), their sera gave very 
similar results when used as complement sources for the immune cytolysis of 
thyrnocytes from six different strains of rats. The presence of rat natural anti- 
bodies (15) apparently does not pose a problem in this system, and rat serum 
provides a convenient source of complement for such testing. 
In addition to exhibiting serological cross-reactivity with 8-AKR, the rat 
theta-like antigen also parallels the 8-antigen of the mouse in its tissue distri- 
bution and developmental kinetics (1, 16). Of particular interest isitsoccurrence 
a t  high concentration in brain tissue. In  both species, neonatal brain expresses 
little or no antigen. During the first few weeks of postnatal life, however, 
expression of the antigen rapidly rises to the adult level. 
The existence in rats of an antigenic system similar to the theta system of 
mice provides a potentially valuable resource for structural and functional 
studies of both the immune system and the nervous system. I t  is recommended 
that the new rat antigen be designated 0-R based upon its homology with the 
mouse 8-antigen. If allelic variants are found, they may be designated 0-R1, 
0-R2, etc. 
Other rat thymus (17-20) and brain (21, 22) antigens have been reported. 
Potworowski and Nairn (17, 18) used BALB/c mouse anti-Lister hooded rat 
TC microsome sera whereas Waksman and his collaborators (19, 20) prepared 
anti-rat TC sera in rabbits. Because BALB/c mice are homozygous for 8C3H, 
anti-8-R-type antibodies might be expected to occur in sera raised against rat 
TC. The relationship between 8-R and the antigens described by Waksman 
are somewhat more difficult to assess. Activity paralleling that of anti-0 serum 
has been observed with rabbit anti-mouse TC and rabbit anti-mouse brain 
sera, but such reagents have not distinguished the genetic variants revealed by 
alloaritisera (23-24). 
SUMMARY 
A rat antigen system parallel to the mouse theta system has been described. 
All rat strains tested expressed an antigen cross-reactive with the 0-AKR 
specificity of mice while none cross-reacted strongly with 8-C3H. The rat anti- 
gen may be demonstrated by either absorption or direct complement-mediated 
killing of rat thymocytes. Patterns of organ distribution and developmental 
appearance in the nervous system of rats also parallel those previously re- 
ported for theta in mice. 
I wish to thank Dr. Ray D. Owen for his counsel and his help in preparation of the manu- 
script. I also express thanks to Dr. David Dusenbery for his helpful discussions and to Eliza- 
beth Blankenhorn for her technical assistance. 
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IV. ADDITIONAL DATA 
Additional s tud ies  of t h e  i n t e r -  and i n t r a s p e c i f i c  d i s t r i b u t i o n  
of Thy-1-like antigens have been undertaken. Absorption experiments 
indica ted  an absence from guinea p ig  b ra in  t i s s u e  of antigens cross- 
r eac t ive  with e i t h e r  Thy-1.1 o r  Thy-1.2. The thymocytes and b r a i n  of 
1 
t h e  degu ( ~ c t o d o n  degus, a South American rodent)  were a l s o  t e s t e d  
f o r  t h e  presence of Thy-1.1 by absorption,  The r e s u l t s  were negative 
eyen though an amount of Thy-1.1 equal t o  one-fourth t h a t  expressed by 
mouse t i s s u e s  would have been read i ly  detected,  
It has not ye t  been poss ib le  t o  exp lo i t  t h e  8-R system as a 
genetic marker i n  t h e  rat because no genet ic  polymorphism i n  t h i s  
antigen has been discovered, I n  an attempt t o  f i n d  such a polymorphism, 
microcytotoxici ty t e s t s  were performed using t h e  thymocytes of f i v e  
inbred s t r a i n s  of r a t s  not included i n  e a r l i e r  experiments (WF/fz, 
COP, A/2, AUG, BN.B~) .* A s  i n  t h e  cases previously described, a l l  
f i v e  of these  s t r a i n s  were found t o  express 8-R. No cross- react iv i ty  
with Thy-1.2 was found. The number of thymocytes from a given r a t  
s t r a i n  required t o  absorb a standard mount of anti-Thy-1.1 antibody 
5 
var ied  from 2.2 x 10 t o  4.3 x lo5 ,  suggesting t h a t  no l a r g e  quanti ta-  
t i v e  differences i n  8-R expression e x i s t  among these  f i v e  s t r a i n s ,  
5 These values a r e  comparable with 2.8 x 10 which was observed f o r  
thymocytes of s t r a i n  WE', 
l ~ e ~ u  t i s s u e s  were a g i f t  from D r .  David Boraker, University of Vermont 
School of Medicine, 
2 ~ h e s e  r a t s  were a g i f t  from Dr, Joy Palm, Wistar I n s t i t u t e ,  Philadelphia.  
29 
I f  a genetic polymorphism for  8-R i s  eventually found, t h e  most 
probable candidates f o r  l inkage s tudies  w i l l  he  those markers already 
known t o  be l inked t o  Thy-1 i n  t h e  mouse, Several  genet ical ly  con- 
t r o l l e d  t r a n s f e r r i n  var ian t s  have been reported i n  Rattus r a t t u s  (22) 
--
but no s imilar  var ia t ion  has been found i n  Rattus norvegicus, 
- 7  , . . . . . . 
~ l e c t r o p h o r e s i s ~  of serum samples from t h e  1 3  inbred and 2 random-bred 
Rattus norvegicus populations re fe r red  t o  above revealed no va r i a t i on  
i n  t h e i r  serum t r ans f e r r i n s ,  
Extracts of kidneys from t h e  same r a t s  were screened f o r  
e lect rophoret ic  var ian t s  of t he  cytoplasmic malic enzyme. Using t he  
buffer  system described i n  chapter 11, t h e  r a t  enzyme migrated anodally 
b 
while t h e  products of ~ o d - l a  and Mod-1 - of t he  mouse migrated cathod- 
a l l y  at  slower r a t e s .  No var ia t ion  i n  t he  e lect rophoret ic  mobi l i ty  
of t h e  enzyme was observed among t h e  15  r a t  populations t e s t ed .  A s  
an addi t ional  check for  poss ible  var ia t ion ,  t h e  buffer  system of 
Richmond (23) was a l so  t r i e d .  Under these  conditions of electrophoresis  
both rat and mouse enzynes migrated anodally, t h e  l a t t e r  moving re la -  
t i v e l y  f a s t e r .  No dif ferences  were observed among the  following 
s t r a i n s :  A / 2 ,  AUG, BN, BN.B2, COP, LEN, WF, WF/fz. 
Additional data  r e l a t i n g  t o  t h e  expression of 8-R antigen by 
various rat lymphoid c e l l  populations have a l so  been gathered. 
Comparative r e s u l t s  of cytotoxic and absorption t e s t s  performed on 
thymus, spleen,  lymph node, and bone marrow c e l l s  of WF r a t s  ( 2 4 )  and 
AKR/J mice a r e  presented i n  Table 2 ,  Although ~hy-1.1' c e l l s  i n  AKR/J 
J See chapter I1 fo r  a descr ipt ion of experimental de t a i l s .  
mouse spleen and lymph node preparations were killed using the same 
antiserum, no significant cytolysis of the corresponding rat cells was 
observed. The differing levels of 8-R expression suggested by these 
results were confirmed by the greatly diminished absorptive capacities 
of rat lymph node and spleen cells relative to thymocytes, 
Although the general pattern of decreased 8-R expression on 
rat lymph node and spleen cells parallels that reported for Thy~l in 
mice (8,25) an important difference between these systems is apparent. 
In rats, 8-R expression on peripheral thymus-derived lymphocytes 
(T-cells) drops below the level of detectability using the absorption 
procedures described above, Acton (26) has obtained similar results 
using quantitative absorption and radioimmunoassay techniques, In 
contrast, the indirect membrane immunofluorescence data of Micheel 
+ 
et al. (27) indicate the presence of 8-R cells in Wistar rat lymph 
- -- 
node and bone marrow. The experiments described in the remainder of 
this chapter were designed to shed additional light upon the question 
of 0-R antigen expression by rat peripheral T-cells, 
The first approach to this question was based upon the hypothesis 
that anti-Thy-1.1 antibodies in the presence of complement might inter- 
fere with rat peripheral T-cell function, even though they did not 
cause cytolysis. The particular function chosen for study was the 
cell-mediated immune destruction of  EL^ (mouse) leukemia cells. 
Ten to sixteen days before cell-mediated imunity was to be 
6 
assayed, mice or rats were injected intraperitoneally with 5 x 10 or 
7 2 x 10  EL^ cells, respectively. On the day of the experiment, 
per i toneal  exudate c e l l s  (PEC) were col lected i n t o  Dulbecco's 
Modified Eagle Medium (DMEM, Grand Is land Biological  C O , )  according 
t o  t h e  method of Berke e t  a l ,  (28) . 
 EL^ a s c i t e s  Leukemia c e l l s  were maintained by s e r i a l  i n t r ay  
per i toneal  passage i n  C57B1/6~ mice. Twenty t o  t h i r t y  mil l ion washed 
EL4 c e l l s  suspended i n  1 m l  of DMEM were incubated with 100 micro- 
0 
cur ies  of ~ a ~ ~ ' ~ r 0  fo r  one and one-half hours at 37 C ,  then washed 4 
f i v e  times i n  3 m l  a l iquo ts  of t he  same medium p r io r  t o  use, The 
r e l a t i v e  proportion of 51~r released from these  prelabeled tumor 
c e l l s  can be used as  a quan t i t a t ive  measure of c e l l  death, arid hence 
cell-mediated immune function,  a f t e r  a correct ion has been applied f o r  
t h e  r e l a t i v e l y  slow r a t e  of spontaneous 51~r e l ea se  (29) .  
One-tenth m l  a l iquo ts  of washed PEC at a concentration of 
7 2.5 x 10 / m l  i n  DMEM were placed i n t o  10 x 75 mm glass  cu l tu re  tubes ,  
Following t h e  addi t ion of 10 micro l i t e r s  of whole mouse normal serum 
or  antiserum t h e  tubes were mixed, covered with p l a s t i c  f i lm,  and 
incubated f o r  15  minutes at room temperature. Forty micro l i t e r s  of 
a su i t ab l e  d i l u t i on  of whole guinea p ig  serum ( ~ i g u r e  8)  o r  20 micro- 
l i t e r s  of undiluted guinea p ig  serum  a able 3 ) ,  which had been s to red  
0 
a t  -70 C until shor t ly  before use,wereadded as a source of complement. 
The tubes were then mixed, covered, and incubated f o r  20 t o  30 minutes 
a t  37'~. A t  t he  end of t h i s  period t he  volume of each tube was  brought 
t o  a t o t a l  of 1 .0  ml by t h e  addit ion of DMEM, Following centr i fugat ion 
a t  360 x g fo r  10 minutes, t h e  supernatants were ca re fu l ly  asp i ra ted  
and discarded so as  t o  minimize t h e  t r ans f e r  of unbound antibodies or 
32 
other  serum components, The p e l l e t  from each tube was resuspended by 
t r i t u r a t i o n  i n  0.9 m l  of DMEM supplemented wi th  10% f e t a l  ca l f  serum 
(DMEM + 10% FCS, s e e  reference  28) and t r a n s f e r r e d  t o  one we l l  of a 
Disposo-Tray ( ~ i n b r o  P l a s t i c s ) ,  
When a l l  of t h e  t r e a t e d  PEC from a s i n g l e  experiment had been 
t r a n s f e r r e d  t o  t h e  coded wel ls  of a t ray ,  0.1 ml of "~r - l abe led   EL^ 
5 leukemia c e l l s  at  a concentrat ion of 5 x 1 0  / m l  i n  DMEM + 10% FCS was 
added t o  each wel l .  The e n t i r e  t r a y  was covered with p l a s t i c  f i l m  and 
incubated on a rocking platform (30) under an atmosphere of 94% a i r  - 
6% Cop f o r  6 hours. A t  t h i s  point  1 m l  of DMEM + 10% FCS w a s  added t o  
each well .  The contents  of  each wel l  were l i g h t l y  t r i t u r a t e d  and 
t r a n s f e r r e d  t o  a disposable 10 x 75 mm glass  c u l t u r e  tube. After  
cen t r i fuga t ion  a t  360 x g f o r  10 minutes, 1 m l  (one-half t h e  t o t a l  
volume) of t h e  supernatant  from each tube was removed f o r  counting i n  
a Nuclear-Chicago Model 4218 wel l  type gamma counter. The remaining 
contents  of each tube w e r e  a l s o  counted. The percentage of 51~r 
re leased  was computed using t h e  following formula: 
2 x (supernatant  - background) Percent 51cr = 
remainder + supernatant  - 2 x background x 100 
where "supernatantw = counts/lO minutes i n  t h e  1 ml supernatant  sample, 
I t  remainder" = counts/ l0 minutes i n  t h e  tube  containing t h e  p e l l e t  p lus  
t h e  o the r  ha l f  of t h e  supernatant ,  and "background" = counts/lO minutes 
with no sample i n  t h e  counting chamber, The f a c t o r  of 2 i n  t h e  numerator 
of t h i s  expression t akes  account of t h e  f a c t  t h a t  only one-half of t h e  
counts re leased frm t h e  labeled  c e l l s  a r e  a c t u a l l y  sampled f o r  counting 
i n  the  "supernatant" tube ,  
3 3 
The results of an experiment using immune AKR/J PEC are shown 
in Figure 8, Immune PEC pretreated with AKR/J mouse normal serum 
uniformly caused maximal tumor cell lysis. In contrast, the cytotoxic 
activity of PEC treated with serum containing antibodies specific for 
Thy-1.1 (8-AKR) was completely abolished. The degree of PEC inactiva- 
tion observed falls off with decreasing complement concentration, 
strongly suggesting that the inactivation process is complementc 
dependent. 
Data from a similar experiment with immune WF rat PEC are pre~ 
sented in Table 3. Each sample of immune PEC was pretreated with 
either AKR/Cum normal serum, A K R / C ~ ~  anti-AKR/J thymocyte serum (con- 
taining anti-Thy-1.1 antibodies), or AKR/Cum anti-BN rat spleen serum, 4 
Rat PEC pretreated with AXR/cum anti-AKR/J thymocyte serum 
showed anti-tumor activity equivalent to those treated with normal 
serum, but pretreatment of these cells with AKR/Cum anti-BN spleen 
serum resulted in a complete inhibition of their cytotoxic activity. 
Thus, the ability of these antisera to interfere with the function of 
WF rat peritoneal cytotoxic cells is correlated with the presence of 
species antibodies, and not of those directed against Thy-1.1, This 
is quite different from the pattern observed for AKR/J immune PEC, 
which are strongly inactivated by either AKR/Cum anti-AKR/J thymocyte 
serum or AKR/Cum anti-BN rat spleen serum, but not by AKR/Cum normal 
serum. 
4 
This serum also contains anti-Thy-1.1 antibodies in addition to anti- 
bodies directed against rat species-specific antigens. The properties of 
this antiserum are discussed further in connection with Figure 9. 
3 4 
The effect of a similar set of antisera on WF rat PEC viability 
was determined in a separate experiment, One-tenth m l  aliquots of PEC 
were pretreated with antibody and complement as described above, The 
viability of the cells in each group was then determined by the Trypan 
Blue exclusion method, It is apparent from the data presented in Table 
4 that the inactivation of rat PEC by AKR/Cum anti-BN rat spleen serum 
is the result of complement-mediated cytolysis, The partial decline 
in the viability of cells treated with either AKR/Cm normal serum or 
anti-Thy-1.1 antibody5 also correlates well with the partial loss of 
effector cell activity observed in similarly treated cell populations 
 able 3). On the basis of these data plus those presented in Table 
2, it seems unlikely that anti-Thy-1.1 reagents can be used for the 
selective elimination of rat peripheral T-cells from mixed lymphoid cell 
populations, as has been done successfully in the mouse, 
The final approach taken in search of 8-R on rat peripheral T- 
cells was based upon the hypothesis that small amounts of this material 
might be immunogenic even though they did not present an adequate 
target for complement-mediated cell damage, In order to evaluate this 
possibility, AKR/Cum mice were injected with BN rat spleen cells 
according to the previously described protocol for raising anti-Thy-l,l 
antibodies. The results of direct complement-dependent cytotoxic tests 
of these sera against thymocytes from mice of strains AKR/C~~, AKR/J, 
+ 
and C3H/HeJ are shown in Figure 9. The specific killing of Thy-1.1 
5 ~ 3 ~ / ~ e ~  anti-AKR/J thymocyte serum rather than AKR-Cum anti&m/J thy- 
mocyte serum was used in this experiment because of its higher titer. 
thymocytes ind ica tes  t h e  presence of anti-Thy-1.1 ant ibodies  i n  t h i s  
antiserum, and hence t h e  presence o r  0-R on r a t  spleen c e l l s ,  
A s  a t e s t  f o r  t h e  presence of emR on o the r  pe r iphera l  T-cells of 
t h e  rat ,  groups of AKR/Cum mice were immunized with WF r a t  c e l l s  taken 
from t h e  mesenteric lymph node, bone marrow, Peyer t s  patches,  pe r i -  
tonea l  cav i ty ,  o r  blood leukocyte f r a c t i o n  of WF r a t s ,  Thymocytes and 
spleen c e l l s  were used as  p o s i t i v e  con t ro l  immunogens, Preliminary 
t e s t s  indica ted  t h e  presence of anti-Thy-1.1 ant ibodies  i n  a l l  groups, 6 
The p r i n c i p a l  object ion t o  t h i s  type of experiment has been 
r a i s e d  by Komuro -- et a l . (31) .  These authors found t h a t  mice lacking 
t h e  TL antigen sometimes produced anti-TL ant ibodies  following irnrnuni- 
+ 
zat ion with spleen c e l l s  from TL donors. This observation was puzzling 
because TL has been repor ted  t o  be present  only on thymocytes, and not 
on pe r iphera l  mouse T-cells ( 7 ) .  Mice thymectomized a s  adu l t s  f a i l e d  
t o  give t h e  a.?n,nmalous response t o  TL although they responded normally 
t o  Thy-1. This f inding was i n t e r p r e t e d  t o  mean t h a t  t h e  o r i g i n a l  spleen 
+ 
c e l l  inoculum contained (TL-, Thy-1 ) stem c e l l s  which d i f f e r e n t i a t e d  
+ i n t o  TL c e l l s  under t h e  inf luence  of t h e  h o s t ' s  thymus, These d i f -  
f e r e n t i a t e d  c e l l s  then evoked an immunological response t o  t h e  TL 
antigen. Experiments designed t o  evaluate  t h e  p o s s i b i l i t y  t h a t  t h i s  i s  
happening i n  t h e  8-R system a r e  cur ren t ly  being pursued i n  col labora t ion 
with Andrew Dowsett, 7 
6 Andrew Dowsett, personal  communication 
7~ndergradurvte, Ca l i fo rn ia  I n s t i t u t e  of Technology 
TABLE 2 
Expression of Thy-1.1 Antigen by WF Rat and AKR/J Mouse Lymphoid Cells 
WF Rat cellsa AKR/J Mouse Cells 
Cytotoxic Absorptive Cytotoxic Absorptive 
b c 
-1,ndex Capacity Index Capacity d Cell Type - 
Thymus 9 3 100 97 100 
Spleen 10 < 3 5 7 5 .O 
Lymph Node 10 < 4 69 597 
Bone Marrow 8 ND' ND <1,5 
a Data from reference (24), which is included as Appendix I 
b~elative to an equivalent number of thymocytes 
C Unpublished data 
d~etermined by Reif and Allen (8), using a somewhat different absorption 
procedure 
e Not done 
TABLE 3 
In  Vi t ro  K i l l i ng  of  EL^ Leukemia Cel ls  by Immune WF Rat Per i toneal  
-- 
Exudate Cells  ( $  51~r ~ e l e a s e d )  
Experiment Number 
Pretreatment of PEC --- 1 2 3 4 5 6  ---- Average 
AKR/Cum Normal Serum 35.3 36,4 32.5 36.2 30.7 28.2 33.2 
AKR/Cum anti-AKR/J 29.0 34,2 35.5 35*1 30.4 32.9 32,9 
Thymocyte Serum 
AKR/Cum anti-BN R a t  
Spleen Serum 
None 
Background 51~r 
Release 
TABLE 4 
Complement - Dependent Cytolysis  of  WF R a t  Per i toneal  Exudate Cells  by 
Mouse Antiserum 
Pretreatment of PEC Viab i l i t y  (%) 
31*_ 
AKR/CU Normal Serum '71 
c3H/HeJ anti-AKR/J 73 
Thymocyte Serum 
A K R / C U ~  anti-BN Rat 3 
Spleen Serum 
None 9 3 
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FIGURE LEGENDS 
Figure 8. -- I n  v i t r o  k i l l i n g  of  EL^ leukemia c e l l s  by immune AKR/J 
mouse per i tonea l  exudate c e l l s .  The percentage of 51~r eleased from 
labeled  EL^ c e l l s  by immune PEC pre t rea ted  with e i t h e r  AKR/J normal 
serum ( 0 )  o r  AKR/Cum anti-AKR/J serum (0 ) w a s  measured, The amount 
of l a b e l  re leased following incubation with no PEC (background r e l ea se )  
o r  untreated PEC i s  shownby(~ )  and ( A ) ,  r e spec t ive ly ,  Each point  repre- 
a 
sen t s  t h e  average of t h r ee  determinations, except those marked , f o r  
which only 2 measurements were made, Error bars  show the  range f o r  
each value. "Complement d i lu t ion"  r e f e r s  t o  t he  conditions under 
which immune PEC were p re t rea ted  ( see  t e x t ) ,  
Figure 9.  Cytotoxic t e s t s  of AKR/Cum anti-BN r a t  spleen serum 
against  mouse thymocytes. Target thymocytes were from s t r a i n  AKR/Cum 
( A ) ,  C3H/HeJ (0 ) , or  AKR/J ( 0 ) .  The microcytotoxici ty procedure 
described e a r l i e r  i n  t h i s  chapter w a s  used. 
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V. GENETIC VARIATION I N  MOUSE THYMOCYTE ANTIGENS 
DETECTED BY HETEROANTISjERA 
The publ ica t ion contained i n  t h i s  chapter  i s  from Transplantat ion.  
It i s  reproduced here with t h e  permission of t h e  W i l l i a m s  and Wilkins 
Company. 
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GENETIC VARIATION IN MOUSE THYMOCYTE ANTIGENS 
DETECTED BY HETEROANTISERA1 
The 0 antigen of the mouse (16) provides a 
vcI1 surface marker for thymus-derived lympho- 
(.ytcs (15, 18). Thc allelic variants of this anti- 
ga, Thy 1 . 1  and Thy 1.2, are expressed by 
animals carrying the Thy-I" or Thy-lb allele, 
resprctivcly (80).  Both specificites are 
exprrssed by mice heterozygous a t  the Thy-1 
10~11s ( I ? ) .  For the purposes of this report, the 
three known Thy-l genotypes are designated 
a/a, a/b, and b/b. 
With one exception (6) )  the genetically deter- 
mined @ specificities have been distinguishable 
only by appropriate alloantisera (prepared by 
intraspecies immunizations). The finding that 
rats express an antigen cross reactive with Thy 
1 . 1  (7,  8, 13) suggested that immunization of 
rats with mouse thymocytes bearing the Thy 
1 . 2  antigen might yield a reagent specific for 
Thy 1.2. Mice of types b/b (A/J, AKR/Cum, 
CBA/.J, C3H/HeJ), a/a (AKR/J, RF/J,  A/ 
Thy-1 . I ) ,  and a/b(CBA/J x RF/J) were used 
to test this hypothesis. 
Inbred female W F  rats received 1 X 10' 
AKR/Cum or C3H/HeJ (b/b) thymocytes sus- 
pended in Hanks' balanced salt solution i.p. each 
week for 6 weeks. Blood was obtained by cardiac 
puncture a t  the end of weeks 1, 5, and 6. Al- 
though antibodies against mouse thjrm~cytcs 
were demonstrable by dye exclusion microcyto- 
toxicity tests2 at the end of the 1st week of 
immunization, the later bleedings showed much 
higher titers, and were pooled for further experi- 
ments. Preimmune sera from the individual rats 
used were all negative in the cytotoxic test. 
Antisera raised against thymocytes of inbred 
female b/b mice (AKR/Cum or C3H/HeJ) 
were complement inactivated by heating a t  56 C 
for 30 min and diluted to 1 :  10 in Hanks' bal- 
anced salt solution. The cytotoxic titer of rat 
anti-AKR/Cum serum was 1 : 640-1 : 1,280 
whether tested against a/a or b/b thymocytes. 
Rat anti-C3H/HeJ titers were 1:320 and 
' Supported by Atomic Energy Commission Con- 
tract AT (04-31-767 and United Stntrs Public 
Health Service Grant GM 00086. 
'The dye exclusion microcytotoxicity test is a 
modification of that describtd by Amos et  al. ( 1 ) .  
Details are given in refsrenee 7. 
1 :64&1: 1,280, respectively, for the two cell 
types. These data reflect the presence of rat 
antimouse species antibodies in these unabsorbed 
hcteroantisera. 
Three-milliliter aliquots of 1 : 10 diluted sera 
were absorbed twice with AKR/J (a/a) red 
blood cells, then twice again with pooled AKR/J 
lymph node, spleen, and thymus cells. One mil- 
liliter of each of the absorbed antisera was then 
absorbed four times with pooled RF/J (a/a) 
lymph node, spleen, and thymus cells. Each ab- 
sorption was carried out for 30 min a t  0 C, and 
used either 0.3 ml of packed, washed erythro- 
cytes or one-fourth of the pooled lymph node, 
spleen, and thymus cells from one donor. 
The results of microcytotoxicity tests using 
these multiply absorbed rat antisera are shown 
in Figure 1. Thymocytes of the b/b strains (A/ 
J ,  AKR/Cum, CBA/J, C3H/HeJ) are selec- 
tively killed relative to those of the a/a strains 
(AKR/J, RF/J) .  Cytolysis is also observed 
when thymocytes from heterozygous (CBA/J x 
RF/J)Fl  mice are used as target cells. The ab- 
sorbed antisera fail to kill thymocytes from mice 
of the congenic stock A/Thy-1 . I ,  which differs 
from the A/J line a t  the Thy-1 locus. While this 
last observation illustrates the presence of anti- 
bodies specigc for the Thy 1.2 antigen, it does 
not prove the absence of other antibodies, be- 
cause the gene(s) for the corresponding anti- 
g e n ( ~ )  might not be present in the A/J back- 
ground. 
As a further test of specificity, thymocytes 
from 10 progeny of the cross (CBA/J x RF/J) 
X RF/J were tested against the absorbed rat 
antisera and also typed for 0 using standard 
alloantisera" (Fig. 2) .  This group of mice in- 
cluded two recombinants involving the linked 
Thy-1 and Trf loci, one of each 0 type. The rat 
anti-AKRlCum serum clearly distinguished two 
classcs of thymocytes (Fig. 2A). These classes 
arc in complete accord with the 0 typing results. 
i.e., Thy-1.2-positive cells are readily killed 
whcrens Thy-1.2-negative cells are not. Consid- 
rrctl in terms of genetic m:lpl)ing, thcsc: rcs111ts 
3 T t ~ r  standard 0 typing sera are AKli/Cum 
anti-AKR/J (anti-Thy-1.1) and AI<II/J ant i- 
C3H/HeJ (anti-Thy-1.2). 
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from two of the six a/a segregants were not 
killed by this serum, but those of the other four 
fell into an intermediate class. This result sug- 
gests file presence of one or more genetic factors 
not closely linked to Thy-I, cont,ributed by the 
CBA/J parent. On the basis of its apparent 
strain distribution (i.e., presence in CBA/J but 
absence in AKR/J and RF/J )  , the antigen giv- 
ing rise to this effect cannot be identified with 
any of the hewn specificities controlled by the 
Tla, Ly-2, or Ly-3 loci (3,  4).  The antigen Ly- 
1 .1  cannot be ruled out on these grounds. The 
I /20 I /40 presence of antibodies to Ly-1.1 is further sug- 
Antiserum Dilution gested by the difference between the two rat 
antisera. Anti-Ly-1 . 1 antibodies might be ex- 
0 
1/20 1 /40 1 /80 
Antiserum Dilut~on 
FIGURE 1. Immune cytolysis of thymocytes from 
inbred and R hybrid mice by absorbed rat anti- 
t\_KR/C?lrn (A)  a d  rat acti-C.?EI/IIeJ ( R )  
reagents. Target cells of genotypes a / a  (AKR/J, 
RF/J, A/Thy-1.1 : O),  a / b  (CBA/J X RF/J  : ), 
and b/b  (A/J, AKR/Cum, CBA/J, C3H/HeJ: A )  
were used. The complement source was unabsorbed 
WF rat norn~al srrum d~luted 1:6 In Hanks' 
balanced salt solution. Cytotoxic index = (% 
stained cells in test well - % stained cells in 
contro1)/(100 - % qtained cells in control). 
strongly suggest that the gene controlling thy- 
mocyte reactivity with this antiserum resides on 
chromosome 9 in the general area of Thy-l  (2, 
10, 1 1 ) .  The evidence therefore indicates that a 
reagent specific for Thy 1.2 can be prepared, by 
appropriate absorption, from the rat antl- 
AKR/Cum serum. 
@ Types :ire :tlso distinguished by the ab- 
sorbed mt anti-CYH/He.T (also b/b)  serum, but 
in tl~is case t h r  I)rrsctnre of nntibodirs dl~ectcd 
against at If,:~ht 01-1~~ ntlthtlonnl t l iymor~~te surface 
conq~o~lcrit ~h indtv:~tod (FIR. 2 R ) .  Th\inoc,ytc? 
Antiserum Dilution 
Antiserum Dilution 
FIGURE 2. Immune cytolysis of thymocyirs from 
10 (CBA/J X RFjJ )  X IIF/J backcross mice by 
nhsorbed rat anti-AKR/Cum ( A )  and r:~t :Inti- 
C3H/HrJ ( R )  rcngcnts. Synil~ols and procrdurr :II'O 
RS in Figure 1. Earlr curvc rcpreseuis t l ~ c  rt~sults ol 
cylotosic assays using target (~,lls fro111 ouc 
111011SC. 
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pected to occur in antisera raised against C3H/ 
HeJ (Ly-1 . l+ ) ,  but not in those raised against 
AKR/Cum (Ly-1 . 1') . Further experiments will 
be nccessary to establish the identity of these 
antibodies. 
In addition to the antigen-antibody systems 
already discussed, the characteristics of the ab- 
sorbed rat antisera described in this report can 
also be distinguished from H-2 (id) .  Little or no 
anti-H-2 activity is expected in these sera be- 
cause strains AKR/Cum and C3H/HeJ, against 
which the sera were raised, as well as strains 
AKR/J and RF/J, with which the sera were 
absorbed, are all homozygous for the H-dk allele 
a t  the major histocompatibility locus. This ex- 
pectation is supported by the differences in reac- 
tivity observed between strains A/J and A/ 
Thy-I. 1, both of which are homozygous for H- 
2". 
Although antisera raised in rabbits against 
mouse thymocyte membranes (5) or brain tissue 
(6, 9) have been reported to show specificity for 
thymus-derived lymphocytes, direct cytotoxicity 
and absorption analyses of these sera have gen- 
erally failed to demonstrate antibodies specific 
for the Thy-1.1 or Thy-1.2 antigens (5 ,  9).  
Similar negative findings have suggested that the . 
immunosuppressive effects of in vivo absorbed 
rabbit antimouse lymphocyte antisera could not 
be attributed to anti-Thy-1 activity per se (19). 
In  contrast, Clagett et al. (6) reported a weak 
specificity for Thy-1.2 in rabbit anti-CBA/ST 
mouse brain serum. These investigators also ob- 
served that rabbit antirat brain sera contain 
antibodies reactive with one or more antigenic 
components (possibly equivalent to Thy-1 . 1) 
present in the brain and thymus of AKR/J mice 
(a/a), but not of eight b/b strains. Other anti- 
gens, apparently unrelated to Thy-I, are shared 
by rat and mouse thymocytes ( 6 ) .  Antibodies di- 
rected against these determinants are probably 
relevant to the immunosuppressive effect of rab- 
bit antirat lymphocyte serum on C3H mice (14). 
The strain distribution and genetic segreg a t' ion 
data presented here show that reagents specific 
for the Thy-1.2 antigen (0 C3H) of the mouse 
can be prepared by the absorption of heteroan- 
tisera raised in rats. I t  seems likely that the 
capacity of rats to produce specific anti-Thy- 
1.2 antibodies is associated with their possession 
of a self antigen indistinguishable from Thy-1. I .  
I n  any case, rat antisera now appear to be a 
ready source of reagents for the detection of a t  
least one class of lymphocyte alloantigens in the 
mouse. 
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V I .  CONCLUSIONS 
The Thyrl antigen of mice and i t s  counterpart BmR i n  r a t s  may be 
viewed from several  d i f f e r en t  perspectives,  It may be considered as  a 
genetic marker, a species-specific antigen,  or  an indicator  of d i f -  
f e r en t i a t i on  at t h e  l e v e l  of t he  whole t i s s u e  or  t he  individual  c e l l ,  
The following discussion w i l l  deal  with Thy-1 as  it appears from each 
of these  viewpoints. 
The Thy-1 locus has become a userul  genet ic  marker f o r  severa l  
reasons. Because t h e  a l l e l i c  a l t e rna t i ve s  a t  t h i s  locus a r e  expressed 
i n  a codominant fashion it i s  poss ible  t o  d i s t ingu ish  heterozygotes 
from e i t h e r  homozygote without t he  necess i ty  of progeny t e s t i n g ,  Dis- 
advantages such as  i n v i a b i l i t y ,  s t e r i l i t y ,  incomplete penetrance, and 
poor e q r e s s i v i t y  which plague some of t h e  other  markers on chromosome 
9 (LG 11) of t h e  mouse do not appear t o  present a problem i n  t h i s  case. 
Pa r t l y  a s  a r e s u l t  of our work t h e  locat ion of Thy-1 with respect  t o  
th ree  of t h e  other most useful  markers on t h i s  chromosome (Tr f ,  Mod-1 
- -9  
d )  has been es tabl ished.  It seems probable t h a t  t h i s  group of l inked 
- 
genes, which i s  some 38 map un i t s  i n  length ,  w i l l  provide a usefu l  land- 
mark fo r  fu tu re  genetic s tudies  of t h i s  chromosome, 
In  i t s  capacity a s  a genetic marker t he  Thy-1 system has been 
applied t o  t he  analysis  of t he  genetic var ia t ion  among sublines of t he  
inbred AKR mouse s t r a i n ,  Unexpectedly, some of these  sublines were 
found t o  express t h e  Thy-1.2 antigen (321, This i s  probably r e l a t e d  t o  
t h e i r  common or ig in  from t h e  Oak Ridge stock,  i n  which t h i s  marker may 
have been segregating, Within t he  context of these  sublines,  animals 
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a homozygous for Thy-1 seem to show an increased susceptibility to 
b 
spontaneous leukemia as compared with those homozygous for -I?& 
If this association is not merely fortuitous because of the limited 
number of strains tested, it may reflect either linkage disequilibrium 
between ,Thy-1 and leukemia susceptibility factors or direct participa- 
tion of the Thy-1 system itself in the process of leukemogenesis, 
Historically, the genetic determinants of alloantigen systems 
have been first described as simple di- or triallelic series, As these 
systems were analyzed more closely, additional genetic complexity was 
often discovered (33). A case in point is the =region of the mouse 
which has been described as "one of the most complex genetic systems 
known" (34). Data suggesting the occurrence of new Thy-1 alleles 
among inbred mouse strains have been presented recently ( 3 5 ) ,  If 
these observations are correct, our understanding of Thy-1 may already 
be on the well-traveled road to complexity. 
In addition to its genetic specificity, Thy-l also shows species 
specificity. The Thy-1.1 antigen is shared by rats and mice but not 
degus. Thy-1.2 has been detected only in mice, and neither antigen has 
been found in hamsters (27) or guinea pigs, This pattern of species 
specificity has made it possible to use defined mouse alloantisera to 
study the rat 0-R antigen, It probably also underlies the successful 
attempts to produce antisera specific for Thy-1.2 in rats, To date it 
has not been possible to raise rat antibodies against 8-R; neither 
qualitative nor quantitative variation in the expression of this antir 
gen has been found among inbred rat strains, 
In  terms of t h e i r  t i s s u e  spec i f i c i t y  and developmental expres- 
s ion,  the  Thy-1 antigen of t h e  mouse and 8-R of t he  r a t  show strong 
s i m i l a r i t i e s ,  The antigens a r e  expressed most p l e n t i f u l l y  i n  b ra in ,  
thymus, and embryonic f i b rob l a s t s  (36) of both species,  I n  t he  mouse 
Thy-1' c e l l s  f i r s t  appear i n  t h e  thymus about day 15 of ges ta t ion,  in- 
creasing i n  number a s  the  organ becomes progressively lymphoid (ll), 
Later, as  thymocytes d i f f e r e n t i a t e  i n t o  per ipheral  TFcells  t he  concen- 
t r a t i o n  of Thy-1 on t h e  c e l l  surface decreases i n  counterpoint with t he  
r i s e  i n  H-2 antigen expression, The ea r ly  s tages  i n  t h e  appearance of 
8-R i n  embryonic r a t  thymus have not been invest igated,  but the  develop- 
mental sequence of ant igenic  expression during l a t e r  T-cell d i f ferenr  
t i a t i o n  appears t o  be s i m i l a r ,  Although some doubt remains as  t o  
whether t h e  0-R antigen i s  expressed a t  a l l  on r a t  per ipheral  T-cells, 
it can be t en t a t i ve ly  concluded t h a t  t he  antigen i s  present i n  small 
m013-t S , 
The temporal changes i n  antigenic expression during bra in  
development i n  t h e  r a t  and mouse a re  v i r t u a l l y  i den t i ca l ,  A t  b i r t h  
l i t t l e  o r  no Thy-1 (o r  8 - R )  i s  present.  Soon afterward an approximately 
logarithmic increase i n  antigen expression begins. This continues 
u n t i l  about day 20, when t he  adu l t  l eve l ,  which exceeds t h a t  i n  t he  
neonate by more than 100-fold, is  reached, 
With each new piece of knowledge about t h e  s p e c i f i c i t y  with 
which Thy-1 o r  8-R i s  expressed, t he  question "What i s  t h e  function of 
t h i s  antigen?" i s  more fo rcefu l ly  implied, The answer i n  t h i s  case,  
as  wel l  as  i n  t h a t  of almost a l l  c e l l  surface antigens,  i s  as  b r i e f  as  
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the question, "Nobody knows," Looking into the future, two avenues 
of exploration show particular promise in this connection, First, it 
may be true that Thy-1 serves as a marker for specific classes of 
cells in the nervous system, much as it; does in the immune system 
(37,38). If this is so, the specialized functions of the cells which 
carry the antigen may provide valuable clues as to the physiological 
role of the antigen itself, Second, the chemical analysis of Thy-1 
antigen molecules solubilized from cell membranes is beginning to 
progress (39-41). The structure of the molecule(s) which carries this 
specificity may be suggestive as to its function, In any case it seems 
likely that the Thy-1 antigen system will continue to be of interest in 
several areas of biological research for some time to come. 
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V I I I .  APPENDIX I 
A RAT ANALOG OF THE MOUSE THETA ANTIGEN 
The publ ica t ion contained i n  t h i s  Appendix i s  from 
Transplantat ion Proceedings. It i s  reproduced here with t h e  
permission of Grune and S t r a t t o n ,  Inc.  
A Rat Analog of the Mouse Theta Antigen 
By T. C. Douglas 
T HE 6 antigen of the mouse1 is of con- siderable interest as an indicator of cel- 
lular differentiation. For example, the rapid 
appearance of theta in the thymic rudiments 
of 14- to 18-day embryos corresponds to 
the developmeht of the lymphoid elements 
of the thymus.2 In adult mice, this antigen 
provides a marker for thymus-derived 
lymphocytes.1.3.4 Developmental changes 
in theta antigen expression have also been 
observed in the nervous system. During 
the first weeks following birth, the mouse 
brain's 6 antigen content rises from near 
zero to a plateau level comparable to that 
expressed by thymocyte~.~.~ 
The two known genetic variants of the 
6 antigen, 6-AKR and 6-C3H, are products 
of the alleles Thy-1" and Thy-lb, respec- 
t i~ely.~-* Anti-6 sera are routinely raised 
by the reciprocal injection of thymocytes 
from inbred strains homozygous for differ- 
ent Thy-1 alleles, but matched at the H-2 
10cus.~ Fuji, Zaleski, and MilgromQ have 
reported that spleen cells from mice im- 
munized against the 6-AKR antigen are 
capable of forming direct plaques against 
rat thymocytes as well as against those of 
mice expressing CAKR. The purpose of the 
experiments reported here was to define 
the extent to which rat thymocyte antigens 
are analogous to the 6 antigen of mice. 
Absorption and trypan blue dye exclusion 
microcytotoxic techniques used in this 
study have been described elsewhere.1° 
SEROLOGICAL SPECIFICITY 
The data shown in Fig. 1 demonstrate 
the absorption of anti-6-AKR cytotoxic 
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antibodies by rat thymocytes. When similar 
absorptions were performed using an anti- 
6-C3H serum of comparable titer, no signif- 
icant suppression of cytotoxicity was 
observed (Fig. 2). These absorption data 
were confirmed by the finding that anti- 
6-AKR sera were cytotoxic for rat thymo- 
cytes in the presence of complement while 
anti-8-C3H sera and normal C3H mouse 
sera were not (Fig. 3). Absorption and 
cytotoxic tests with thymocytes from rats 
of eight inbred (ACI, BN, BUF, D, DA, 
F344, LEW, WF)ll and two random bred 
(Wistar, Holtzman) stocks all yielded simi- 
lar results. The presumed common rat 
thymic antigen responsible for this spe- 
cific immunological cross-reactivity is des- 
ignated 6-R. 
TISSUE DISTRIBUTION 
In contrast to the results obtained with 
thymus, homogenates of other rat organs 
such as liver, lung, testis, cardiac muscle, 
and skeletal muscle showed iittie or no 
absorption of anti-6-AKR cytotoxic anti- 
bodies. The only marked exception to this 
pattern was brain, which showed a high 
absorptive capacity. 
The 6-R antigen also exhibited a distinc- 
tive distribution on cells of the lymphoid 
organs. The results of cytotoxic and ab- 
sorption tests using WF rat thymus, spleen, 
lymph node, and bone marrow cells are 
shown in Table I. Although &bearing cells 
in AKR/J mouse spleen and lymph node 
preparations were killed using the same 
antiserum, no significant cytoloysis of the 
corresponding rat cells was observed. The 
different levels of 6-R antigen expression 
suggested by these results were confirmed 
by the greatly diminished absorptive capac- 
ities of lymph node and spleen cells relative 
to thymocytes. Although the general pat- 
tern of decreased 6-R expression on rat 
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Antiserum Di lut ion 
Fig. 1. Killing of AKR/J thymocytes by 
C3H/HeJ anti-AKR/J serum. Of serum di- 
luted 1/32 in Hanks' balanced salt solution 
0.1-ml aliquots were absorbed with the 
following numbers of thymocytes: none 
(closed circles), 1 X lo7 DA rat (open cir- 
cles), 1 X lo7 AKR/J (triangles). Comple- 
ment: 1 /12 agarose-absorbed rabbit serum. 
lymph node and spleen cells parallels that 
reported for the 8 antigen of mice,l an 
important difference between these systems 
is apparent. Anti-8 sera have been widely 
used for the selective elimination of thy- 
mus-dependent lymphocytes from hetero- 
genous cell  population^.^ The failure to 
observe significant killing of rat spleen and 
lymph node cells by anti-8-AKR sera sug- 
gests that this strategy may not be of use 
with rat cells. 
DEVELOPMENTAL ANTIGEN EXPRESSION 
IN THE BRAIN 
Of anti-8-AKR serum diluted 1:256 in 
Hanks' balanced salt solution 0.05-mI ali- 
quots were absorbed with 2150 g pellets 
Table 1. Expression of 8-R Antigen on 
WF Rat Cells 
Cytotoxic 
Cell Index Absorptive 
TYPE (Ole) Capacity 
Thymus 93 100 
Spleen 10 <3 
Lymph node 10 <4 
Bone marrow 8 ND* 
'No data. 
Fig. 2. Killing of C3HlHeJ thymocytes by 
AKR/J anti-C3H/HeJ serum. Symbols and 
procedure same as in Fig. 1. Absorption with 
1 X lo7 C3HIHeJ thymocytes (squares). 
from saline homogenates representing 
known wet weights of brain tissue. The 
absorptive capacity of a given sample was 
defined as the reciprocal of the number of 
milligrams of brain homogenate (G) required 
to produce a 50% inhibition of cytotoxicity 
using this standard serum and AKR/J 
target  cell^.^^*'^ As may be seen in Fig. 4, 
the 6-absorptive capacity of WF rat brain 
increases rapidly from birth (day 0) 
through about day 20 of postnatal life. 
Complex patterns of cellular proliferation, 
Antiserum Dilution 
Fig. 3. Complement-mediated cytotoxicity 
of WF rat thymocytes by anti-6 serum. Sera: 
C3H/HeJ anti AKR/J (squares), AKR/J anti 
C3HlHeJ (triangles), C3HlHeJ normal serum 
(open circles). Complement: 11'4 WF rat 
serum. 
THETA ANTIGEN 
Fig. 4. Developmen- 
tal appearance of 6-R 
specificity in WF rat 
brain. Serum: AKRI 
Cum anti-AKR/J.16 At 
age 1 day, absorptive 
capacity <0.04. 
migration, and differentiation contribute to 
the process of neurogenesis during this 
developmental period.14 Further data relat- 
ing the expression of 8-R antigen to these 
changes may prove to be of great interest. 
SUMMARY 
The occurrence of a rat antigen, des- 
ignated 8-R, has been reported. This anti- 
gen resembles the 8 antigen of mice in 
several respects. Absorption and direct 
cytotoxic tests showed specific cross-reac- 
tivity between 6-R and the 6-AKR, but not 
the O-C3H specificity. Except for the brain 
lOOr 
and thymus, which are rich in 8-R, the 
other rat organs tested showed little or 
none of this antigen. The reduced expres- 
sion of 8-R on spleen, lymph node, and 
bone marrow cells relative to thymocytes 
also resembles the distribution of 8. Finally, 
the developmental kinetics of 8-R in the rat 
brain closely parallel those reported for 8 
in the mouse. These characteristics of 8-R 
clearly place it in the category of the "dif- 
ferentiation antigens,"15 and point to the 
potential usefulness of this system for 
studies of neurophysiological as well as im- 
munological development in the rat. 
c '0- 
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